Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 17, 2001

View Archived Issues

Biotech Industry Backs Patent Ruling; Parliament Reticent

Language Gene Hailed As Cognitive Genetics Landmark

French Biotech Industry Calls For US$3.6B In State Support

Switch Biotech Raises EUR18M, Moves Focus To Development

Hybrigenics, Institut Pasteur Extend Proteomics Alliance

Huntingdon Life Moving To U.S. Market Due To Activism

Xenovas Genital Herpes Trial Fails; Glaxo Opts Out Of Deal

CAT Enters First Collaboration In Area Of Infectious Disease

Genmab Enters Development Deals With Immunex, Scancell

Other News To Note

Proteome Scinces Completes US$7M Funding Of Subsidiary

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 9, 2025.
Corestemchemon preps US BLA filing for stem cell ALS therapy
BioWorld
Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...
In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol
BioWorld
In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
Omada, Caris arrivals continue med-tech IPO hot streak
BioWorld MedTech
Omada Health Inc. rang the opening bell on the New York Stock Exchange on June 6, marking its first day as a public company, but it won’t be the most recent IPO...